Oncopharmpod
Pembrolizumab Nets 2 More Approvals
- Author: Vários
- Narrator: Vários
- Publisher: Podcast
- Duration: 0:15:02
- More information
Informações:
Synopsis
Discussing recent FDA-approvals of pembrolizumab for metastatic or unresectable, recurrent Head & Neck Cancer (1st line) and Small Cell Lung Cancer (3rd line)
